APA (7th ed.) Citation

Mahnoor, Jahan, S., Elahi, L., Zakria, M., Rabia, Ikram, M., & Ullah, N. (2025). Alpha‐Linolenic Acid for Mitigating Neuroinflammation and Dopaminergic Neuronal Loss in Parkinson's Disease: Insights From In Vivo and In Silico Studies. Clinical & Experimental Pharmacology & Physiology, 52(6), 1. https://doi.org/10.1111/1440-1681.70043

Chicago Style (17th ed.) Citation

Mahnoor, Sarwat Jahan, Laila Elahi, Muhammad Zakria, Rabia, Muhammad Ikram, and Najeeb Ullah. "Alpha‐Linolenic Acid for Mitigating Neuroinflammation and Dopaminergic Neuronal Loss in Parkinson's Disease: Insights From In Vivo and In Silico Studies." Clinical & Experimental Pharmacology & Physiology 52, no. 6 (2025): 1. https://doi.org/10.1111/1440-1681.70043.

MLA (9th ed.) Citation

Mahnoor, et al. "Alpha‐Linolenic Acid for Mitigating Neuroinflammation and Dopaminergic Neuronal Loss in Parkinson's Disease: Insights From In Vivo and In Silico Studies." Clinical & Experimental Pharmacology & Physiology, vol. 52, no. 6, 2025, p. 1, https://doi.org/10.1111/1440-1681.70043.